| Jul 12 |
Verona (VRNA) Stock Surges 36% in the Past Month: Here's Why
|
| Jul 10 |
Indivior (INDV) Down on Dropping Schizophrenia Drug, Cuts '24 View
|
| Jul 2 |
The past three years for Compugen (NASDAQ:CGEN) investors has not been profitable
|
| Jun 17 |
Compugen to Present at Upcoming Antibody Industrial Symposium
|
| Jun 4 |
Compugen (CGEN) Could Find a Support Soon, Here's Why You Should Buy the Stock Now
|
| May 30 |
Compugen to Receive Milestone Payment Triggered by Dosing of First Patient in the Second Phase 3 Trial Evaluating Rilvegostomig
|
| May 22 |
Earnings Release: Here's Why Analysts Cut Their Compugen Ltd. (NASDAQ:CGEN) Price Target To US$5.00
|
| May 20 |
Compugen Ltd. (CGEN) Q1 2024 Earnings Call Transcript
|
| May 20 |
Compugen (CGEN) Reports Q1 Loss, Misses Revenue Estimates
|
| May 20 |
Compugen GAAP EPS of -$0.08 beats by $0.03, revenue of $2.56M beats by $1.35M
|
